Core Viewpoint - Daoshi Technology announced an investment of $30 million in Qiangna Technology to acquire minority shareholder rights, aiming to enhance its capabilities in AI and new materials, particularly in the application of carbon materials in key components like electronic skin [2]. Group 1: Company Overview - Daoshi Technology, established in 2007 and listed in December 2014, focuses on carbon materials, lithium battery materials, and ceramic materials, with key products including graphene conductive agents and carbon nanotube conductive agents [3]. - In the first half of 2025, Daoshi Technology reported revenue of 3.654 billion yuan, a year-on-year decrease of 11.64%, while net profit attributable to shareholders increased by 108.16% to 230 million yuan, with basic earnings per share at 0.32 yuan [3]. Group 2: Investment and Strategic Direction - The investment in Qiangna Technology is part of Daoshi Technology's strategy to leverage Qiangna's expertise in brain-computer interface technology across medical rehabilitation, educational consumption, and human-computer interaction [2]. - Daoshi Technology has been actively developing a collaborative R&D system for "AI + materials" and announced plans to establish a computing center to enhance its research capabilities [3]. Group 3: Qiangna Technology Profile - Qiangna Technology, recognized as one of the "Six Little Dragons of Hangzhou," specializes in non-invasive brain-computer interface technology, with core products including smart bionic hands and legs [2]. - The company has a strong technical barrier and commercialization capability, with over 460 authorized patents and its core products certified by international standards such as FDA and CE [2].

Core Insights - Daoshi Technology's subsidiary, Hong Kong Jian Na, has signed a Pre-B round preferred stock subscription agreement with Brain Family Inc., investing $30 million to acquire minority equity in the company [1] - Brain Family Inc. is a leading global company in brain-computer interface technology, holding over 460 authorized patents and having core products certified by FDA and CE, applicable in various fields such as medical rehabilitation and human-computer interaction [1] - Daoshi Technology aims to leverage its experience in materials to build an "AI + materials" platform, collaborating with Brain Family Inc. to enhance the commercialization capabilities of "AI + new materials" [1] Company and Industry Summary - The development of brain-computer interface technology is significantly influenced by materials science, as demonstrated by the non-invasive approach of Brain Family Inc. in controlling smart prosthetics through sensors that capture weak human brain signals [2] - The breakthrough in materials science allows for the development of sensor materials that can more sensitively and stably capture original signals without the need for conductive gel, simplifying the user experience [2] - Brain-computer interface technology is a composite technology requiring support from various fields, including neuroscience, materials science, artificial intelligence algorithms, and engineering [2]

Group 1 - The core viewpoint of the news is that Daoshi Technology is investing in Brain Family Inc. to enhance its capabilities in AI and new materials, particularly in the application of brain-computer interface technology [1] - Daoshi Technology's subsidiary, Hong Kong Jiana, plans to invest $30 million in Brain Family Inc. to acquire minority shareholder rights [1] - Brain Family Inc. is recognized as one of the "Six Little Dragons of Hangzhou" and specializes in non-invasive brain-computer interface technology, with over 460 authorized patents and products certified by FDA and CE [1] Group 2 - Daoshi Technology, established in 2007 and listed in 2014, focuses on carbon materials, lithium battery materials, and ceramic materials, with major products including graphene conductive agents and ceramic inks [2] - In the first half of 2025, Daoshi Technology reported revenue of 3.654 billion yuan, a year-on-year decrease of 11.64%, while net profit attributable to shareholders increased by 108.16% to 230 million yuan [2] - The significant profit growth is attributed to the expansion of overseas business, increased production capacity of cathode copper, and rising cobalt metal prices, which improved the gross margin of cobalt products [2] Group 3 - Daoshi Technology is establishing an intelligent computing center to integrate atomic-level computing with AI algorithms, aiming to transform traditional material R&D from experience-based to data-driven approaches [3] - The company has formed strategic partnerships with Suzhou Nengsida Electronic Technology Co., Ltd. and Xinpeisen to accelerate the application of carbon materials in key components for humanoid robots [3]

Core Viewpoint - The company announced a significant investment in a leading brain-computer interface technology firm, aiming to enhance its competitive edge and commercial capabilities in various sectors [1] Investment Details - The company's subsidiary, Hong Kong Jiana, signed a Pre-B round preferred stock subscription agreement with Qiangnao Technology and its subsidiaries, committing to invest 30 million USD [1] - The completion of the transaction is subject to approval by Qiangnao Technology's board and specific shareholders [1] Company Profile of Qiangnao Technology - Qiangnao Technology is recognized as a global leader in brain-computer interface technology, possessing unique technological barriers and commercialization capabilities [1] - The core team of Qiangnao Technology includes members from prestigious institutions such as Harvard and MIT, and the company holds over 460 authorized patents [1] - Its core products have received international certifications, including FDA and CE, and are widely applied in fields such as medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1] Strategic Goals - The company aims to leverage Qiangnao Technology's experience in applying brain-computer interface technology to enhance its "AI + new materials" ecosystem and commercialization capabilities [1] - The investment is expected to accelerate the application of the company's carbon material products in key components like electronic skin, thereby strengthening its core competitiveness and supporting long-term stable development [1]

智通财经APP讯，道氏技术(300409.SZ)公告，公司控股子公司香港佳纳有限公司(简称"香港佳纳")于近 日与标的公司强脑科技及其下属控股子公司(合称"强脑科技")及其他相关方共同签订《Pre-B轮优先股认 购协议》。该交易将在强脑科技根据其章程规定经董事会及特定股东审议通过后完成交割。香港佳纳使 用自有资金出资3000万美金认购标的公司Pre-B轮优先股，从而获得标的公司少数股东权益。 公告称，强脑科技为全球领先的脑机接口技术公司，在脑机接口领域具备稀缺的技术壁垒和商业化能 力。公司核心团队多来自哈佛、MIT等顶尖院校，已获授权专利460余项，核心产品已通过FDA、CE等 国际认证，并广泛应用于医疗康复、教育科技、消费健康、人机交互和泛娱乐等多个领域。公司拟借助 强脑科技在医疗康复、教育消费和人机交互领域应用脑机接口技术的经验，进一步增强"AI+新材料"生 态赋能与商业化落地能力，同时推进公司碳材料产品在电子皮肤等关键零部件领域应用的进程，提升公 司核心竞争力，为公司长期稳定发展寻求有力支撑。 ...

Core Insights - Daoshi Technology (300409.SZ) announced that its subsidiary, Hong Kong Jiana Co., Ltd., has signed a Pre-B round preferred stock subscription agreement with Brain Family Inc. and related parties [1] - The transaction will be completed after approval from Brain Family Inc.'s board and specific shareholders [1] - Hong Kong Jiana will invest $30 million to acquire minority equity in Brain Family Inc. [1] Company Overview - Brain Family Inc. is a global leader in brain-computer interface technology, possessing significant technological barriers and commercialization capabilities [1] - The core team of Brain Family Inc. includes members from top institutions such as Harvard and MIT [1] - The company holds over 460 authorized patents and its core products have received international certifications from FDA and CE [1] Application Fields - Brain Family Inc.'s technology is widely applied in various sectors, including medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1]

转自：证券时报 人民财讯9月2日电，道氏技术(300409)9月2日晚间公告，公司控股子公司香港佳纳有限公司（简称"香 港佳纳"）近日与强脑科技及其下属控股子公司及其他相关方共同签订《Pre-B轮优先股认购协议》。该 交易将在强脑科技根据其章程规定经董事会及特定股东审议通过后完成交割。香港佳纳拟出资3000万美 元认购强脑科技Pre-B轮优先股，从而获得强脑科技少数股东权益。 公司拟借助强脑科技在医疗康复、教育消费和人机交互领域应用脑机接口技术的经验，进一步增 强"AI+新材料"生态赋能与商业化落地能力，同时推进公司碳材料产品在电子皮肤等关键零部件领域应 用的进程。 ...

Core Viewpoint - Daoshi Technology (300409.SZ) announced a significant investment in Brain Family Inc. through its subsidiary Hong Kong Jiana, acquiring minority equity in the company by subscribing to Pre-B round preferred shares for $30 million [1] Company Summary - Hong Kong Jiana, a subsidiary of Daoshi Technology, will invest $30 million in Brain Family Inc. to acquire minority shareholder rights [1] - Brain Family Inc. is a leading global company in brain-computer interface technology, possessing unique technological barriers and commercialization capabilities [1] - The core team of Brain Family Inc. includes members from prestigious institutions such as Harvard and MIT, and the company holds over 460 authorized patents [1] - Brain Family Inc.'s core products have received international certifications from FDA and CE, and are widely used in various fields including medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1]

道氏技术公告，控股子公司香港佳纳拟使用自有资金出资3000万美元认购强脑科技Pre-B轮优先股，从 而获得其少数股东权益。强脑科技是一家全球领先的脑机接口技术公司，在脑机接口领域具备稀缺的技 术壁垒和商业化能力。本次投资旨在把握AI时代发展机遇，进一步增强"AI+新材料"生态赋能与商业化 落地能力，提升公司核心竞争力。 ...

证券代码：300409 证券简称：道氏技术 公告编号：2025-094 广东道氏技术股份有限公司 关于控股子公司对外投资的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 广东道氏技术股份有限公司（以下简称"公司"）控股子公司香港佳纳有 限公司（以下简称 " 香港佳纳" ）于近日与 Brain Family Inc.（以下简称 "标 的公司"、"强脑科技"）及其下属控股子公司（合称"强脑科技"）及其他 相关方共同签订《Pre-B 轮优先股认购协议》（以下简称"认购协议"）。该交 易将在强脑科技根据其章程规定经董事会及特定股东审议通过后完成交割。香 港佳纳使用自有资金出资 3,000.00 万美金认购标的公司 Pre-B 轮优先股，从而 获得标的公司少数股东权益。 一、对外投资概述 二、标的公司的基本情况 强脑科技（Brain Family Inc.）为全球领先的脑机接口技术公司，在脑机接 口领域具备稀缺的技术壁垒和商业化能力。公司核心团队多来自哈佛、MIT 等 顶尖院校，已获授权专利 460 余项，核心产品已通过 FDA、CE 等国际认证， 并广泛应用于医 ...